Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11933| Title: | A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization. | Austin Authors: | Kao, Yung Hsiang | Affiliation: | Austin Hospital Level 1, Harold Stokes Building 145 Studley Rd. Melbourne, Victoria 3084, Australia E-mail: | Issue Date: | 6-Nov-2013 | Publication information: | Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 2013; 54(12): 2191-2 | Gov't Doc #: | 24198389 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/11933 | DOI: | 10.2967/jnumed.113.128553 | Journal: | Journal of Nuclear Medicine | URL: | https://pubmed.ncbi.nlm.nih.gov/24198389 | Type: | Journal Article | Subjects: | Embolization, Therapeutic Female Humans Liver.metabolism.radiation effects Male Microspheres Resins, Synthetic.chemistry Technetium Tc 99m Aggregated Albumin.diagnostic use |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.